Previous Close | 0.5400 |
Open | 0.5100 |
Bid | 0.5100 x 0 |
Ask | 0.5500 x 0 |
Day's Range | 0.5100 - 0.5100 |
52 Week Range | 0.2200 - 0.7500 |
Volume | |
Avg. Volume | 17,426 |
Market Cap | 34.033M |
Beta (5Y Monthly) | 0.63 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0500 |
Earnings Date | May 23, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 3.60 |
CARLSBAD, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a manufacturer of innovative spinal implants, today announced the FDA clearance of a new Lumbar Spinal Stenosis Indication for Use for its ZIP™ family of MIS implants. Spinal Stenosis occurs when the spinal canal narrows which can lead to back and leg pain. Adding Lumbar Spinal Stenosis to the existing FDA-cleared indications of degenerative disc disease, spo
CARLSBAD, Calif., June 13, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of United States Patent No: 11,331,199 entitled "Spinal Implant for Motion Preservation or Fusion." This patent covers Aurora's ZIPFlex™ Technology for a minimally invasive posterior interlaminar implant for motion preservation that cou
CARLSBAD, Calif, June 06, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it had received FDA 510(k) clearance for its DEXA SOLO-L™ spinal fusion system. The 3D printed standalone anterior lumbar interbody fusion device (ALIF) was developed as part of the world’s first bone density matched implant based on Aurora’s pa